Oxytocin Administration in High-Intensity Focused Ultrasound Treatment of Myomata

Abstract EN

Objectives.

The aim of the study was to evaluate the clinical efficacy of magnetic resonance-guided High-Intensity Focused Ultrasound (HIFU) in patients with symptomatic uterine fibroids (myomata) after application of oxytocin.

Methods.

156 women with symptomatic uterine fibroids were treated using MR-guided HIFU procedure.

51 patients had additional IV administration of 40 IU of oxytocin in 5% Glucose or 0,9% NaCl solution during therapy.

Before and after the procedure we performed MR and measured initial perfused volume, final perfused volume, nonperfused volume (NPV), and treated volume ratio (TVR).

The follow-up was up to 15 months to assess efficacy of treatment and relief of symptoms.

Results.

Nonperfused volume was statistically significantly larger in oxytocin group than in control group (p=0.0019).

The remaining parameters did not show significant difference between both groups.

Conclusion.

Oxytocin administration seems to improve efficiency of HIFU therapy although further research is required to assess its value.

This study’ clinical registration number is DRKS00014794.